— Know what they know.
Not Investment Advice

LCI NYSE

Lannett Company, Inc.
1W: +47.4% 1M: -79.3% 3M: -98.7% 1Y: -99.6% 3Y: -100.0% 5Y: -100.0%
$0.69
Last traded 2023-05-23 — delisted
NYSE · Healthcare · Drug Manufacturers - Specialty & Generic · $7.4M mcap · 8M float · 2.48% daily turnover

Revenue Segmentation

By Product / Service

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$341M -28.9% ▼
5Y CAGR: -11.8%
Gross Profit
$33M -56.1% ▼
5Y CAGR: -35.8%
Operating Income
-$70M -321.5% ▼
Net Income
-$232M +36.3% ▲
EPS (Diluted)
$-22.96 -902.6% ▼
EBITDA
-$118M -862.1% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2018FY2019FY2020FY2021FY2022
Revenue$685M$655M$546M$479M$341M
YoY Growth+7.4%-4.3%-16.7%-12.3%-28.9%
Cost of Revenue$396M$412M$381M$403M$307M
Gross Profit$289M$244M$165M$76M$33M
Gross Margin42.2%37.2%30.3%15.8%9.7%
R&D Expenses$29M$39M$30M$24M$22M
SG&A Expenses$82M$88M$79M$68M$81M
Operating Expenses$111M$126M$109M$92M$103M
Operating Income$130M$60M-$1M-$17M-$70M
Operating Margin18.9%9.1%-0.3%-3.5%-20.6%
Interest Expense$86M$85M$67M$54M$58M
Income Before Tax$51M-$346M-$49M-$303M-$234M
Tax Expense$22M-$74M-$15M$61M-$2M
Net Income$29M-$272M-$33M-$363M-$232M
Net Margin4.2%-41.5%-6.1%-75.9%-68.0%
EPS (Diluted)$0.19$-1.76$-0.21$-2.29$-22.96
EBITDA$192M$116M$54M-$18M-$118M
Shares Outstanding153M155M156M159M10M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms